A Phase IV, Multi-centre, Randomised, Double-Blind Study to Evaluate the Efficacy and Safety of NK- 104 versus Atorvastatin in Chinese Patients with Hypercholesterolaemia
Phase 4
- Conditions
- Hypercholesterolaemia
- Registration Number
- JPRN-jRCT2080221598
- Lead Sponsor
- Kowa Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 480
Inclusion Criteria
Patients diagnosed with hypercholesterolaemia
Exclusion Criteria
1.Any conditions which may cause secondary dyslipidemia
2.Uncontrolled diabetes mellitus
3.Any surgical or medical condition which might significantly alter the absorption, distribution, metabolism, or excretion of any drug
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method